开云体育
L. E. Porter
All authors
About
Publications While At 开云体育
selected publications
Journal Article
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
.
Lancet (London, England).
2010
Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
.
Lancet (London, England).
2008
Contact
full name
L. E.
Porter
Quick Info
Publications
Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science